Volume 9, Number 7—July 2003
Synopsis
Disease Surveillance and the Academic, Clinical, and Public Health Communities
Table 2
Syndrome | Etiology (n) | Tests (n) |
---|---|---|
Neurologic (n=15) |
Neisseria meningitidis (4) |
16S rDNA PCR (2), PCR (1), EIA IgM (1)a |
Bartonella hensaelae (1) |
PCR, IFA, IgG |
|
Bartonella spp. (2) |
IFA, IgG |
|
Chlamydia pneumoniae (1) |
MIF, IgG |
|
Mycoplasma pneumoniae (1) |
EIA, IgM/IgG |
|
Cytomegalovirus (1) |
EIA and IFA,IgG |
|
Coxsackie B (1) |
EIA,IgM, viral culture |
|
Enterovirus (1) |
EIA,IgM |
|
Epstein-Barr virus (1) |
IFA,IgG (VCA and EA) |
|
Human herpes virus 6 (1) |
IFA and EIA (IgM and IgG) |
|
Mumps virus (1) |
IFA IgM, IFA and EIA, IgG |
|
Respiratory (n=13) |
Chlamydia pneumoniae (2) |
MIF IgG (2), IFA, IgM |
Mycoplasma pneumoniae (4) |
PCR (blood), EIA, IgM/IgG |
|
Streptococcus pneumoniae (2) |
16S rDNA PCR (pleural fluid) |
|
Legionella spp. (1) |
PCR (from lung) |
|
Adenovirus (1) |
EIA and IFA, IgG |
|
Influenza B virus (1) |
EIA and IFA, IgG |
|
Influenza A virus (1) |
EIA and IFA, IgM, EIA (IgG) |
|
Human parainfluenza virus types 1 and 3 (1) |
EIA and IFA, IgG |
|
Cardiac (n=3) |
Borrelia burgdorferi/Ehrlichia chaffeensis (1) |
EIA/IFA flagella, IgG, Western Blot (IgG and IgM) |
Enterovirus (1) |
EIA IgM |
|
Legionella spp. (1) |
PCR (heart) |
|
Multisystem (n=3) | Neisseria meningitidis (1) |
PCR (cerebrospinal fluid) |
Adenovirus (1) |
PCR (blood) |
|
Enterovirus (1) | IgM, EIA |
a PCR, polymerase chain reaction; EIA, enzyme immunosorbent assay; IFA, indirect immunofluorescent assay; IG, immunoglobulin; MIF, microimmunofluorescence.
bReference 12.
References
- Gerberding JL, Hughes JM, Koplan JP. Bioterrorism preparedness and response: clinicians and public health agencies as essential partners. JAMA. 2002;287:898–90. DOIPubMedGoogle Scholar
- Petersen LR, Marfin AA. West Nile virus: a primer for the clinician. Ann Intern Med. 2002;137:173–9.PubMedGoogle Scholar
- Centers for Disease Control and Prevention. West Nile virus activity—United States, September 26–October 2, 2002, and investigations of West Nile virus infections in recipients of blood transfusion and organ transplantation. MMWR Morb Mortal Wkly Rep 2002;51:884,895.
- Institute of Medicine. Emerging infections: microbial threats to health in the United States. Washington: National Academy Press; 1992.
- Centers for Disease Control and Prevention. Addressing emerging infectious disease threats: a prevention strategy for the United States. Atlanta: U.S. Department of Health and Human Services, Public Health Service; 1994.
- Centers for Disease Control and Prevention. Preventing emerging infectious diseases: a strategy for the 21st Century. Atlanta: U.S. Department of Health and Human Services, Public Health Service; 1998.
- Hardnett FP, Hoekstra RM, Kennedy MH, Angulo FJ; EIP Foodnet Working Group. Comparability of FoodNet and United States populations. Poster presented at: International Conference on Emerging Infectious Diseases; 24–27 March 2002; Atlanta, Ga.
- Schuchat A, Hilger T, Zell E, Farley MM, Reingold A, Harrison L, Active bacterial core surveillance of the emerging infections program network. Emerg Infect Dis. 2001;7:92–9. DOIPubMedGoogle Scholar
- Centers for Disease Control and Prevention. Foodborne diseases active surveillance network. MMWR Morb Mortal Wkly Rep. 1997;46:258–61.PubMedGoogle Scholar
- Herikstad H, Yang S, Van Gilder TJ, Vugia D, Hadler J, Blake P, A population-based estimate of the burden of diarrhoeal illness in the United States: FoodNet, 1996–7. Epidemiol Infect. 2002;129:9–17. DOIPubMedGoogle Scholar
- Mead PS, Slutsker L, Dietz V, McCaig LF, Bresee JS, Shapiro C, Food-related illness and death in the United States. Emerg Infect Dis. 1999;5:607–25. DOIPubMedGoogle Scholar
- Hajjeh RA, Relman D, Cieslak PR, Sofair AN, Passaro D, Flood J, Surveillance for unexplained deaths and critical illnesses due to possibly infectious cases, United States, 1995–1998. Emerg Infect Dis. 2002;8:145–53. DOIPubMedGoogle Scholar
- Perkins BA, Flood JM, Danila R, Holman RC, Reingold AL, Klug LA, Unexplained deaths due to possibly infectious causes in the United States: defining the problem and designing surveillance and laboratory approaches. Emerg Infect Dis. 1996;2:47–53. DOIPubMedGoogle Scholar
- Ijdo JW, Meek JI, Cartter ML, Magnarelli LA, Wu C, Tenuta SW, Emergence of another tickborne infection in the 12-town area around Lyme, CT: human ehrlichiosis. J Infect Dis. 2000;181:1388–93. DOIPubMedGoogle Scholar
- Centers for Disease Control and Prevention. Surveillance for Creutzfeldt-Jakob disease—United States. MMWR Morb Mortal Wkly Rep. 1996;45:665–8.PubMedGoogle Scholar
- Centers for Disease Control and Prevention. Preventing pneumococcal disease among infants and young children: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep. 2000;49(RR-9):1–35.PubMedGoogle Scholar
- Robinson KA, Baughman W, Rothrock G, Barrett NL, Pass M, Lexau C, Epidemiology of invasive Streptococcus pneumoniae infections in the United States, 1995–1998: opportunities for prevention in the conjugate vaccine era. JAMA. 2001;285:1729–35. DOIPubMedGoogle Scholar
- Centers for Disease Control and Prevention. Notice to readers: decreasing availability of pneumococcal conjugate vaccine. MMWR Morb Mortal Wkly Rep. 2001;50:783.
- Whitney CG, Farley MM, Hadler J, Harrison LH, Bennet NM, Lynfield R, Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. N Engl J Med. 2003;348:1737–46. DOIPubMedGoogle Scholar
- Whitney CG, Farley MM, Hadler J, Harrison LH, Lexau C, Reingold A, Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States. N Engl J Med. 2000;343:1917–24. DOIPubMedGoogle Scholar
- Heffelfinger JD, Dowell SF, Jorgensen JH, Klugman KP, Mabry LR, Musher DM, Management of community-acquired pneumonia in the era of pneumococcal resistance: a report from the drug-resistant Pneumococcus pneumonia therapeutic working group. Arch Intern Med. 2000;160:1399–408. DOIPubMedGoogle Scholar
- Schrag SJ, Zywicki S, Farley M, Reingold A, Harrison L, Lefkowitz L, Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis: population-based surveillance in the United States, 1993–1998. N Engl J Med. 2000;342:15–20. DOIPubMedGoogle Scholar
- Centers for Disease Control and Prevention. Early-onset group B streptococcal disease-United States, 1998–1999. MMWR Morb Mortal Wkly Rep. 2000;49:793–6.
- Schrag SJ, Zell ER, Lynfield R, Roome A, Arnold KE, Craig AS, A population-based comparison of strategies to prevent early-onset group B streptococcal disease in neonates. N Engl J Med. 2002;347:233–9. DOIPubMedGoogle Scholar
- Schrag S, Gorwitz R, Fultz-Butts K, Schuchat A. Prevention of perinatal group B streptococcal disease. Revised guidelines from the CDC. MMWR Morb Mortal Wkly Rep. 2002;51(RR-11):1–22.PubMedGoogle Scholar
- Hyde TB, Hilger TM, Reingold A, Farley MM, O’Brien KL, Schuchat A. Trends in the incidence and antimicrobial resistance of early-onset sepsis: population-based surveillance in San Francisco and Atlanta. Pediatrics. 2002;110:690–5. DOIPubMedGoogle Scholar
- Baltimore RS, Huie SM, Meek JI, Schuchat A, O’Brien KL. Early-onset neonatal sepsis in the era of group B streptococcal prevention. Pediatrics. 2001;108:1094–8. DOIPubMedGoogle Scholar
- Centers for Disease Control and Prevention. Preliminary FoodNet data on the incidence of foodborne illnesses—select sites, United States, 2001. MMWR Morb Mortal Wkly Rep. 2002;51:325–9.PubMedGoogle Scholar
- Centers for Disease Control and Prevention. Diagnosis and management of foodborne illnesses. MMWR Morb Mortal Wkly Rep. 2001;50(RR-2):1–69.PubMedGoogle Scholar
- Duchin JS, Koster FT, Peters CJ, Simpson GL, Tempest B, Zaki SR, Hantavirus pulmonary syndrome: a clinical description of 17 patients with a newly recognized disease. N Engl J Med. 1994;331:546–8.PubMedGoogle Scholar
- Zaki SR, Khan AS, Goodman RA, Armstrong LR, Greer PW, Coffield LM, Retrospective diagnosis of hantavirus pulmonary syndrome, 1978–1993: implications for emerging infectious diseases. Arch Pathol Lab Med. 1996;120:134–9.PubMedGoogle Scholar
- Park SY, Glaser C, Murray WJ, Kazacos KR, Rowley HA, Frederick DR, Raccoon roundworm (Baylisascaris procyonis) encephalitis: case report and field investigation. Pediatrics. 2000;106:e56. DOIPubMedGoogle Scholar
- Asnis DS, Conetta R, Teixeira AA, Waldman G, Sampson BA. The West Nile virus outbreak of 1999 in New York: the Flushing Hospital experience. Clin Infect Dis. 2000;30:413–8. DOIPubMedGoogle Scholar
- Centers for Disease Control and Prevention. Update: Clostridium novyi and unexplained illness among injecting drug users—Scotland, Ireland, and England, April–June 2000. MMWR Morb Mortal Wkly Rep. 2000;49:543–5.PubMedGoogle Scholar
Page created: December 22, 2010
Page updated: December 22, 2010
Page reviewed: December 22, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.